02561.HK
VISEN Pharmaceuticals
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 19.04
−0.31%Margins
Gross margin
18.5%
EBITDA margin
-1154.2%
EBIT margin
-1157.2%
Net margin
-1173.9%
FCF margin
-2254.3%
-35.7%
Return on equity
-27.0%
Return on assets
-27.8%
Return on invested capital
0.02x
Asset turnover
-HKD 535.4M
Cash from operations
HKD 5.70
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026